Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


30.12.2018

2 Am Heart J
1 Ann Thorac Surg
4 Arterioscler Thromb Vasc Biol
1 Atherosclerosis
1 BMJ
1 Circ Res
31 Circulation
2 Clin Cardiol
1 Hypertension
1 Int J Cardiol
7 J Am Coll Cardiol
1 J Electrocardiol
1 J Thorac Cardiovasc Surg
3 JAMA
1 Lancet
1 Mayo Clin Proc
2 N Engl J Med
2 PLoS One
1 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. GIBSON CM, Kerneis M, Yee MK, Daaboul Y, et al
    The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.
    Am Heart J. 2018;208:81-90.
    PubMed     Text format     Abstract available

  2. DOLL JA, Hellkamp AS, Thomas L, Fonarow GC, et al
    The association of pre- and posthospital medication adherence in myocardial infarction patients.
    Am Heart J. 2018;208:74-80.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. AL KINDI HN, Yacoub MH
    Transection & Relocation of anomalous left coronary artery following aborted sudden cardiac death.
    Ann Thorac Surg. 2018 Dec 18. pii: S0003-4975(18)31837.
    PubMed     Text format     Abstract available


    Arterioscler Thromb Vasc Biol

  4. MATSUURA Y, Kanter JE, Bornfeldt KE
    Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.
    Arterioscler Thromb Vasc Biol. 2019;39:e1-e9.
    PubMed     Text format    

  5. UELAND T, Akerblom A, Ghukasyan T, Michelsen AE, et al
    Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes.
    Arterioscler Thromb Vasc Biol. 2018 Dec 6:ATVBAHA118311042.
    PubMed     Text format     Abstract available

  6. SHEA S, Stein JH, Jorgensen NW, McClelland RL, et al
    Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.
    Arterioscler Thromb Vasc Biol. 2019;39:89-96.
    PubMed     Text format     Abstract available

  7. RAGGI P, Senior P, Shahbaz S, Kaul P, et al
    (18)F-Sodium Fluoride Imaging of Coronary Atherosclerosis in Ambulatory Patients With Diabetes Mellitus.
    Arterioscler Thromb Vasc Biol. 2018 Nov 29:ATVBAHA118311711.
    PubMed     Text format     Abstract available


    Atherosclerosis

  8. SOARES AAS, Carvalho LSF, Bonilha I, Virginio VW, et al
    Adverse interaction between HDL and the mass of myocardial infarction.
    Atherosclerosis. 2018;281:9-16.
    PubMed     Text format     Abstract available


    BMJ

  9. TIMMIS A, Wragg A
    Coronary intervention for stable angina.
    BMJ. 2018;363:k5351.
    PubMed     Text format    


    Circ Res

  10. TRINCOT CE, Xu W, Zhang H, Kulikauskas MR, et al
    Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Cx43.
    Circ Res. 2018 Oct 11. doi: 10.1161/CIRCRESAHA.118.313835.
    PubMed     Text format     Abstract available


    Circulation

  11. LEMESLE G
    Aspirin on Top of Anticoagulation in Patients with Concomitant Stable Coronary Artery Disease and Atrial Fibrillation: No Clear Answer Yet.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037440.
    PubMed     Text format    

  12. LLOYD-JONES DM, Braun LT, Ndumele CE, Smith SC Jr, et al
    Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Circulation. 2018 Nov 10:CIR0000000000000638. doi: 10.1161/CIR.0000000000000638.
    PubMed     Text format     Abstract available

  13. FITCHETT D, Inzucchi SE, Cannon CP, McGuire DK, et al
    Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
    Circulation. 2018 Dec 6. doi: 10.1161/CIRCULATIONAHA.118.037778.
    PubMed     Text format     Abstract available

  14. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    PubMed     Text format     Abstract available

  15. O'DONOGHUE ML, Fazio S, Giugliano RP, Stroes ESG, et al
    Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial.
    Circulation. 2018 Nov 30. doi: 10.1161/CIRCULATIONAHA.118.037184.
    PubMed     Text format     Abstract available

  16. SOUSA GR, Pober D, Galderisi A, Lv H, et al
    Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus: A DCCT/EDIC Cohort-Based Study.
    Circulation. 2018 Nov 26. doi: 10.1161/CIRCULATIONAHA.118.036068.
    PubMed     Text format     Abstract available

  17. BRESS AP, Colantonio LD, Cooper RS, Kramer H, et al
    Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Circulation. 2019;139:24-36.
    PubMed     Text format     Abstract available

  18. KUFNER S, Joner M, Thannheimer A, Hoppmann P, et al
    Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038065.
    PubMed     Text format     Abstract available

  19. MCGUIRE DK, Alexander JH, Johansen OE, Perkovic V, et al
    Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038352.
    PubMed     Text format     Abstract available

  20. MAULER M, Herr N, Schoenichen C, Witsch T, et al
    Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
    Circulation. 2018 Oct 25. doi: 10.1161/CIRCULATIONAHA.118.033942.
    PubMed     Text format     Abstract available

  21. FAN Q, Tao R, Zhang H, Xie H, et al
    Dectin-1 Contributes to Myocardial Ischemia-Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.
    Circulation. 2018 Sep 27. doi: 10.1161/CIRCULATIONAHA.118.036044.
    PubMed     Text format     Abstract available

  22. MATSUMURA-NAKANO Y, Shizuta S, Komasa A, Morimoto T, et al
    An Open-Label Randomized Trial Comparing Oral Anticoagulation with and without Single Antiplatelet Therapy in Patients with Atrial Fibrillation and Stable Coronary Artery Disease Beyond One Year after Coronary Stent Implantation: The OAC-ALONE Study.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.036768.
    PubMed     Text format     Abstract available

  23. FEARON WF, Achenbach S, Engstrom T, Assali A, et al
    Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037350.
    PubMed     Text format     Abstract available

  24. FANAROFF AC, Zakroysky P, Wojdyla D, Kaltenbach LA, et al
    Relationship Between Operator Volume and Long-Term Outcomes after Percutaneous Coronary Intervention: A Report from the NCDR CathPCI Registry.
    Circulation. 2018 Sep 12. doi: 10.1161/CIRCULATIONAHA.117.033325.
    PubMed     Text format     Abstract available

  25. BANGALORE S
    The Elusive Late Benefit of Biodegradable Polymer Drug Eluting Stents.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038378.
    PubMed     Text format     Abstract available

  26. PRABHAKARAN D, Jaacks LM
    Reflections From India on Scaling Up Risk Factor Control for Cardiovascular Diseases to Reach 1 Billion Adults.
    Circulation. 2019;139:4-6.
    PubMed     Text format    

  27. KATZ S, Smilowitz NR, Hochman JS
    Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038279.
    PubMed     Text format     Abstract available

  28. PENCINA MJ, Navar AM, Wojdyla D, Sanchez RJ, et al
    Quantifying Importance of Major Risk Factors for Coronary Heart Disease.
    Circulation. 2018 Dec 7. doi: 10.1161/CIRCULATIONAHA.117.031855.
    PubMed     Text format     Abstract available

  29. SCHRAGE B, Ibrahim K, Loehn T, Werner N, et al
    Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.036614.
    PubMed     Text format     Abstract available

  30. KHERA AV, Chaffin M, Zekavat SM, Collins RL, et al
    Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035658.
    PubMed     Text format     Abstract available

  31. KAPUR NK, Alkhouli M, DeMartini T, Faraz H, et al
    Unloading the Left Ventricle Before Reperfusion in Patients with Anterior ST-Segment Elevation Myocardial Infarction: A Pilot Study Using the Impella CP((R)).
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038269.
    PubMed     Text format     Abstract available

  32. ARORA S, Stouffer GAR, Kucharska-Newton A, Qamar A, et al
    Twenty Year Trends and Sex Differences in Young Adults Hospitalized with Acute Myocardial Infarction: The ARIC Community Surveillance Study.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.037137.
    PubMed     Text format     Abstract available

  33. THIELE H, Zeymer U, Thelemann N, Neumann FJ, et al
    Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038201.
    PubMed     Text format     Abstract available

  34. VAN LEEUWEN MAH, van der Hoeven NW, Janssens GN, Everaars H, et al
    Evaluation of Microvascular Injury in Revascularized Patients with ST Elevation Myocardial Infarction Treated with Ticagrelor versus Prasugrel: The REDUCE-MVI Trial.
    Circulation. 2018 Oct 30. doi: 10.1161/CIRCULATIONAHA.118.035931.
    PubMed     Text format     Abstract available

  35. DAI Y, Song J, Li W, Yang T, et al
    RhoE Fine-Tunes Inflammatory Response in Myocardial Infarction.
    Circulation. 2018 Oct 5. doi: 10.1161/CIRCULATIONAHA.118.033700.
    PubMed     Text format     Abstract available

  36. VANHAVERBEKE M, Bogaerts K, Sinnaeve PR, Janssens L, et al
    Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:137-139.
    PubMed     Text format    

  37. JOLLY SS, James S, Dzavik V, Cairns JA, et al
    Response by Jolly et al to Letters Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1103-e1104.
    PubMed     Text format    

  38. SHAH R
    Letter by Shah Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1101-e1102.
    PubMed     Text format    

  39. JURADO-ROMAN A, Sanchez-Perez I, Lozano-Ruiz-Poveda F
    Letter by Jurado-Roman et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1099-e1100.
    PubMed     Text format    

  40. KARAMASIS GV, Davies JR, Clesham GJ
    Letter by Karamasis et al Regarding Article, "Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration".
    Circulation. 2017;135:e1097-e1098.
    PubMed     Text format    

  41. OEMRAWSINGH RM, Akkerhuis KM, de Mulder M, Umans VA, et al
    High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.
    Circulation. 2019;139:134-136.
    PubMed     Text format    


    Clin Cardiol

  42. IBRAHIM NE, McCarthy CP, Shrestha S, Gaggin HK, et al
    A Clinical, Proteomics, and Artificial Intelligence-Driven Model to Predict Acute Kidney Injury in Patients Undergoing Coronary Angiography.
    Clin Cardiol. 2018 Dec 23. doi: 10.1002/clc.23143.
    PubMed     Text format     Abstract available

  43. GREENBERG B, Peterson ED, Berger JS, Laliberte F, et al
    Ejection Fraction, B-type Natriuretic Peptide and Risk of Stroke and Acute Myocardial Infarction among Patients with Heart Failure.
    Clin Cardiol. 2018 Dec 22. doi: 10.1002/clc.23140.
    PubMed     Text format     Abstract available


    Hypertension

  44. SCHUTTE AE
    Early Detection of Cardiovascular Risk in Children.
    Hypertension. 2018 Dec 10:HYPERTENSIONAHA11812239.
    PubMed     Text format    


    Int J Cardiol

  45. SAAD M, Stiermaier T, Fuernau G, Poss J, et al
    Impact of direct stenting on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction.
    Int J Cardiol. 2018 Dec 3. pii: S0167-5273(18)33741.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  46. GHORBANI A, Bhambhani V, Christenson RH, Meijers WC, et al
    Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes.
    J Am Coll Cardiol. 2018;72:3246-3254.
    PubMed     Text format     Abstract available

  47. LOW WANG CC, Blomster JI, Heizer G, Berger JS, et al
    Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
    J Am Coll Cardiol. 2018;72:3274-3284.
    PubMed     Text format     Abstract available

  48. PURI R, Reed GW
    Refining Coronary Stent Platforms in the Modern DES Era: Thinning, Eluting, Inhibiting, and Absorbing.
    J Am Coll Cardiol. 2018;72:3298-3300.
    PubMed     Text format    

  49. CALIFF RM
    Future of Personalized Cardiovascular Medicine: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:3301-3309.
    PubMed     Text format     Abstract available

  50. GUERIN M, Silvain J, Gall J, Darabi M, et al
    Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2018;72:3259-3269.
    PubMed     Text format     Abstract available

  51. BAILEY SR, Beckman JA, Dao TD, Misra S, et al
    ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Intervent
    J Am Coll Cardiol. 2018 Dec 4. pii: S0735-1097(18)38674.
    PubMed     Text format    

  52. KRUL IM, Opstal-van Winden AWJ, Janus CPM, Daniels LA, et al
    Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma.
    J Am Coll Cardiol. 2018;72:3374-3375.
    PubMed     Text format    


    J Electrocardiol

  53. RUIZ-MATEOS B, Garcia-Borbolla R, Almendro-Delia M, Seoane-Garcia T, et al
    Localization of the culprit artery in inferior myocardial infarction: Influence of the point of measurement of ST segment.
    J Electrocardiol. 2018;53:8-12.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  54. PROVOST B, Pluchon K, Bezon E
    Which place could the radial artery take in coronary artery bypass grafting?
    J Thorac Cardiovasc Surg. 2018 Nov 10. pii: S0022-5223(18)32918.
    PubMed     Text format    


    JAMA

  55. LOTTA LA, Wittemans LBL, Zuber V, Stewart ID, et al
    Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    JAMA. 2018;320:2553-2563.
    PubMed     Text format     Abstract available

  56. WADHERA RK, Joynt Maddox KE, Wasfy JH, Haneuse S, et al
    Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.
    JAMA. 2018;320:2542-2552.
    PubMed     Text format     Abstract available

  57. FONAROW GC
    Unintended Harm Associated With the Hospital Readmissions Reduction Program.
    JAMA. 2018;320:2539-2541.
    PubMed     Text format    


    Lancet

  58. COLOMBO A, Giannini F
    Encouraging data from ABSORB IV pave the way to new scaffolds.
    Lancet. 2018;392:1490-1491.
    PubMed     Text format    


    Mayo Clin Proc

  59. MAY HT, Lappe DL, Knowlton KU, Muhlestein JB, et al
    Prediction of Long-Term Incidence of Chronic Cardiovascular and Cardiopulmonary Diseases in Primary Care Patients for Population Health Monitoring: The Intermountain Chronic Disease Model (ICHRON).
    Mayo Clin Proc. 2018 Dec 18. pii: S0025-6196(18)30612.
    PubMed     Text format     Abstract available


    N Engl J Med

  60. WADHERA RK, Bhatt DL
    Toward Precision Policy - The Case of Cardiovascular Care.
    N Engl J Med. 2018;379:2193-2195.
    PubMed     Text format    

  61. MATSUURA H, Ohya M
    Coronary-Artery Occlusion from Kawasaki's Disease.
    N Engl J Med. 2018;379:e42.
    PubMed     Text format    


    PLoS One

  62. ANJANA RM, Unnikrishnan R, Mugilan P, Jagdish PS, et al
    Causes and predictors of mortality in Asian Indians with and without diabetes-10 year follow-up of the Chennai Urban Rural Epidemiology Study (CURES - 150).
    PLoS One. 2018;13:e0197376.
    PubMed     Text format     Abstract available

  63. YANG TH, Chuang FC, Kuo HC
    Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction.
    PLoS One. 2018;13:e0198764.
    PubMed     Text format     Abstract available


    Thromb Haemost

  64. TSCHARRE M, Vogel B, Tentzeris I, Freynhofer MK, et al
    Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Dec 28. doi: 10.1055/s-0038-1676563.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: